These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20105399)

  • 1. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
    Pinzani V; Giniès E; Robert L; Peyrière H; Abbar M; Blayac JP
    Rev Med Interne; 2000 Mar; 21(3):282-4. PubMed ID: 10763190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal reactions associated with venlafaxine.
    Parker G; Blennerhassett J
    Aust N Z J Psychiatry; 1998 Apr; 32(2):291-4. PubMed ID: 9588310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant use during pregnancy. FPIN’s clinical inquiries.
    Patel BN; Beste J; Blackwell JC
    Am Fam Physician; 2011 May; 83(10):1211-5. PubMed ID: 21568258
    [No Abstract]   [Full Text] [Related]  

  • 5. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Venlafaxine and its discontinuation syndrome].
    Sierra Santos L; Raigal Martín Y; Ortega García A; Barriochoa Martínez de Pisón C; Aparicio Jabalquinto G
    Aten Primaria; 1999 Dec; 24(10):617-8. PubMed ID: 10659465
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
    Papadimitriou GN; Theleritis CG; Papageorgiou CC; Kalogeromitros D; Syrigou E; Gregoriou S; Rabavilas AD
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1019. PubMed ID: 16922966
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shock-like sensations during venlafaxine withdrawal.
    Reeves RR; Mack JE; Beddingfield JJ
    Pharmacotherapy; 2003 May; 23(5):678-81. PubMed ID: 12741444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal syndrome after discontinuation of venlafaxine.
    Agelink MW; Zitzelsberger A; Klieser E
    Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
    [No Abstract]   [Full Text] [Related]  

  • 13. Withdrawal reactions associated with low-dose venlafaxine treatment in a patient with premenstrual dysphoric disorder.
    Hsiao MC; Liu CY
    J Clin Psychiatry; 2004 Aug; 65(8):1147-8. PubMed ID: 15323606
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of venlafaxine discontinuation symptoms with ondansetron.
    Raby WN
    J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
    Hanekamp BB; Zijlstra JG; Tulleken JE; Ligtenberg JJ; van der Werf TS; Hofstra LS
    Neth J Med; 2005 Sep; 63(8):316-8. PubMed ID: 16186642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.
    Bakish D
    Postgrad Med; 1999 Nov; 106(6 Suppl):24-30. PubMed ID: 19667501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine withdrawal reactions.
    Louie AK; Lannon RA; Kirsch MA; Lewis TB
    Am J Psychiatry; 1996 Dec; 153(12):1652. PubMed ID: 8942467
    [No Abstract]   [Full Text] [Related]  

  • 20. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.